Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.81
-0.30 (-2.29%)
At close: Mar 24, 2026, 4:00 PM EDT
13.17
+0.36 (2.81%)
After-hours: Mar 24, 2026, 7:53 PM EDT
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.51 billion as of March 24, 2026. Its market cap has increased by 41.24% in one year.
Market Cap
1.51B
Enterprise Value
1.00B
1-Year Change
41.24%
Ranking
Category
Stock Price
$12.81
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.51B, an increase of 99.77%. That is a compound annual growth rate of 7.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 1.55B | 48.73% |
| Dec 31, 2025 | 1.04B | -12.32% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
| May 6, 2016 | 757.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innoviva | 1.61B |
| Harmony Biosciences Holdings | 1.60B |
| Vericel | 1.59B |
| Novavax | 1.57B |
| Generate Biomedicines | 1.56B |
| Iovance Biotherapeutics | 1.52B |
| Immunocore Holdings | 1.52B |
| Nurix Therapeutics | 1.48B |